| 非HT组 (n = 213) | HT组 (n = 53) | X2/Z/t值 | P |
年龄 | 64.16 ± 11.31 | 68.48 ± 8.48 | 3.04 | 0.003 |
男 | 130 (61.0) | 30 (56.6) | 0.347 | 0.556 |
高血压 | 159 (74.6) | 44 (83.0) | 1.645 | 0.200 |
糖尿病 | 99 (46.5) | 27 (50.9) | 0.629 | 0.643 |
房颤 | 13 (6.1) | 6 (11.3) | 1.044 | 0.187 |
入院NIHSS评分 | 3 (2, 6) | 8 (3, 10) | 6.639 | <0.001 |
卒中病因分型 |
|
| 3.477 | 0.430 |
大动脉粥样硬化型 | 89 (41.8) | 32 (60.4) |
|
|
小动脉闭塞型 | 120 (56.3) | 18 (34.0) |
|
|
心源性栓塞 | 4 (1.9) | 3 (5.6) |
|
|
预后 |
|
| 32.813 | <0.001 |
预后良好 | 151 (70.9) | 15 (28.3) |
|
|
预后不良 | 62 (29.1) | 38 (71.7) |
|
|
白细胞(×109/L) | 6.49 ± 1.4 | 7.31 ± 1.23 | 9.183 | <0.001 |
中性粒细胞细胞百分比(%) | 60.42 ± 10.34 | 71.87 ± 7.55 | 12.437 | <0.001 |
淋巴细胞百分比(%) | 29.7 (23.3, 35.15) | 19.9 (15.25, 23.23) | 7.308 | <0.001 |
血小板计数(×1012/L) | 221.54 ± 46.55 | 239.88 ± 61.82 | 2.42 | 0.016 |
NLR | 2.11 (1.56, 2.83) | 3.61 (2.93, 5.04) | 7.481 | <0.001 |
PLR | 7.3 (5.9, 9.84) | 12.59 (9.75, 14.98) | 7.846 | <0.001 |
SII (×109/L) | 447.21 (321.67, 622.32) | 881.17 (757.63, 1170.15) | 8.044 | <0.001 |
肌酐(umol/L) | 59 (49, 71) | 59 (48, 73.5) | 0.049 | 0.961 |
空腹血糖(mmol/L) | 6.15 (5.17, 8.93) | 6.23 (5.31, 8.04) | 0.097 | 0.923 |
胆固醇(mmol/L) | 5.29 ± 1.18 | 5.42 ± 1.29 | 0.636 | 0.525 |
甘油三酯(mmol/L) | 1.38 (0.98, 1.86) | 1.07 (0.86, 1.7) | 1.548 | 0.122 |
高密度脂蛋白(mmol/L) | 1.31 ± 0.28 | 1.33 ± 0.23 | 0.386 | 0.700 |
低密度脂蛋白(mmol/L) | 3.36 ± 0.99 | 3.54 ± 1.05 | 1.075 | 0.283 |
同型半胱氨酸(μmol/L) | 12.2 (10.35, 15.00) | 12.55 (10.53, 15.70) | 0.870 | 0.384 |
国际标准化比值 | 0.89 (0.47, 1.03) | 0.96 (0.61, 1.04) | 1.494 | 0.135 |
糖化血红蛋白(mmol/L) | 7.15 ± 1.99 | 7.06 ± 1.93 | 0.303 | 0.762 |